Tobacco Free Initiative (TFI)

7th Meeting of the WHO Study Group on Tobacco Product Regulation

Date: 4-6 December 2013
Place: Rio de Janeiro, Brazil

Participants at 7th Meeting of the WHO Study Group on Tobacco Product Regulation (TobReg) in Rio de Janeiro, Brazil
WHO/Dr Ghazi S. Zaatari
Participants at 7th Meeting of the WHO Study Group on Tobacco Product Regulation (TobReg) in Rio de Janeiro, Brazil

The 7th meeting of WHO Study Group on Tobacco Product Regulation (WHO TobReg) focused on issues critical to advancing the field of tobacco product regulation, particularly as outlined at the 5th session of the Conference of Parties to the WHO Framework Convention on Tobacco Control (WHO FCTC) in paragraph 3(b) of decision FCTC/COP5(6) and paragraphs 1-4 of decision FCTC/COP5(10) . The agenda items planned for this WHO TobReg meeting included:

  • the evolution of new tobacco products and other related modified risk products;
  • nicotine reduction and addictiveness;
  • reduced ignition propensity (RIP) cigarettes;
  • a comprehensive list of toxicants and carcinogens;
  • electronic nicotine delivery systems (ENDS);
  • smokeless tobacco.

This meeting is part of the process of crafting documents for presentation at the 6th session of the Conference of Parties in October 2014. The resulting WHO TobReg advisory opinions will also be compiled into WHO TobReg's 5th technical report series, which will be presented at the January 2015 WHO Executive Board 136th session. This is a closed working group meeting for WHO TobReg members, key facilitators of the Articles 9 and 10 Working Group of the Conference of the Parties to the WHO FCTC, the Convention Secretariat and the WHO Tobacco Free Initiative.

The 7th meeting of WHO TobReg took place in Rio de Janeiro on 4-6 December 2013 through the generous support of its Brazilian host, the National Health Surveillance Agency (ANVISA). ANVISA is a member of the WHO Tobacco Laboratory Network (TobLabNet) and represents Brazil as one of the key facilitators in the Articles 9 and 10 Working Group of the Conference of the Parties to the WHO FCTC.

WHO TobReg, previously known as the Scientific Advisory Committee on Tobacco Product Regulation (SACTob), advises WHO on scientifically sound recommendations for Member States to achieve the most effective and evidence-based means to fill regulatory gaps in tobacco control, to develop a coordinated regulatory framework for tobacco products, to guide international policy and to facilitate access to scientific information. Its membership is drawn from national and international experts on product regulation, tobacco dependence treatment, risk assessment, marketing, toxicology, disease reduction, environmental tobacco smoke, water pipes, smokeless tobacco, and laboratory analysis of tobacco contents, emissions and design features.

Share